Investors Accuse Dialysis Provider DaVita of Ethics Breach

Saying an illegal profit-goosing scheme has already invited regulatory scrutiny and cost dialysis provider DaVita more than a billion dollars in market capitalization, shareholders brought a derivative class action to keep the company in line.

Read more